A Comparison of Dalteparin and Tinzaparin for Prevention of Blood Clots in Hemodialysis Patients on Oral Anticoagulants Having Surgery

NCT00260988 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

COMPLETED

Status

29

Enrollment

OTHER

Sponsor class

Conditions

Thromboembolism
Hemodialysis

Interventions

DRUG: Fragmin (dalteparin)
DRUG: Innohep (tinzaparin)

Sponsor

Ottawa Hospital Research Institute

Collaborators

[object Object]